healthcare-entrepreneur
(10)
Stas Sokolin
Stas Sokolin is the co-founder and CEO of Amae Health, a specialty integrated-care company for people with severe mental illness. A former impact investor at the Chan Zuckerberg Initiative with earlier stints at Google X and the American Medical Association's Health2047, he started his career as an investment banking analyst at BNP Paribas before setting out to rebuild how the hardest cases in behavioral health are treated - using in-person clinics, multidisciplinary teams, and a data platform built on Palantir. In November 2025 Amae raised a $25 million Series B led by Altos Ventures, pushing its total funding past $50 million.
Ilya Budik
Ilya Budik is the CEO of CardioRenal Systems, a Milford, Massachusetts medical device company behind the RenalPro System (sold as RenalGuard outside the U.S.), a technology built to prevent acute kidney injury in cardiac surgery, interventional cardiology, and ICU patients. A medtech executive with roughly a decade of experience across strategy, finance, and business development, he has steered the company through FDA Breakthrough Device Designation, CE Mark approval abroad, and an FDA IDE approval clearing the way for a U.S. pivotal trial. He previously led the neurodiagnostics company NeuroQuest and worked in innovation strategy and healthcare finance.
Jeffery Ryan
Jeffery Ryan is the co-founder, president, and CEO of Interscope, Inc., a Massachusetts medical device company behind the EndoRotor System, a mechanical, non-thermal tool for interventional gastroenterology and pulmonology. A former U.S. Air Force captain who moved into medical device sales at Medtronic and Smith & Nephew, Ryan launched Interscope in 2013 with physician co-founder Dr. Ramon A. Franco, Jr., steering the EndoRotor from concept to FDA clearances and a 2020 distribution partnership with Micro-Tech Endoscopy.
Michael Wilson
Michael G. Wilson is the founder and CEO of Healthcare Highways, a Frisco, Texas company that builds high-performance provider networks for self-funded employer health plans. He was a five-time All-American gymnast at the University of Oklahoma, the 1979 NCAA floor exercise champion, and made the 1980 U.S. Olympic team that never competed because of the Moscow boycott. Over more than four decades in healthcare, he has founded or built PPO Oklahoma, Corporate Health Plans of America, Texas TrueChoice, Century Healthcare, and Healthcare Highways.
Danish Qureshi
Danish Qureshi is the founder and CEO of Zarminali Pediatrics, a nationwide pediatric multispecialty group he started in 2024 to fix the fragmented way American children get care. Before Zarminali, he co-founded LifeStance Health, scaling it into the country's largest outpatient mental health provider with thousands of clinicians across dozens of states before it went public. A former Bain consultant and private equity operator who cut his teeth in wound care, Qureshi has raised roughly $150M for Zarminali and grown it to nearly 30 clinics across eight states in under two years.
Chris Johnson
Chris Johnson is the founder and CEO of Bluebird Kids Health, a value-based pediatric primary care company building clinics in 'pediatric care deserts' where children, many of them on Medicaid, lack access to a regular doctor. After scaling Landmark Health's in-home senior care from 12 to 38 states ahead of its acquisition by Optum, Johnson partnered with venture studio Juxtapose and veteran pediatrician Dr. Shannon Fox-Levine to bring the same outcomes-aligned model to kids. Bluebird now serves more than 20,000 patients, raised $31.5 million in 2025, and is expanding across Florida.
Warren Olsen
Warren Olsen is the Chairman and Chief Executive Officer of Gallus Medical Detox Centers (Gallus Detox and Recovery Services), a Colorado-based behavioral-health company headquartered in the Denver area. He leads a roughly 44-person organization built around a clinician-founded care model, steering its growth, brand, and multi-site operations after the company raised seed capital in 2022.
Aram Salzman
Aram Salzman is the CEO and co-founder of AngioWave Imaging, a Boston-area medtech company building AI that sharpens the blurry, fast-moving X-ray movies cardiologists rely on during heart catheterizations. He is a serial healthcare founder whose earlier company, NovoBiotic Pharmaceuticals, produced teixobactin, the first new class of antibiotic discovered in decades. He also co-founded and exited CRA Health and Boston Lighthouse Innovations.
Eric Meizlish
Eric Meizlish is the CEO of Cardiosense, a Chicago digital health company building AI-enabled, non-invasive cardiac monitoring. A Yale-trained investor turned healthcare operator, he co-founded the clinical analytics firm Lumere (sold to GHX), ran the life-sciences procurement platform Prendio-BioProcure, and started his career investing in tech and media at Citadel. He took the Cardiosense top job in September 2025 to scale the company's CardioTag sensor, which predicts pressures and volumes inside the heart without an implant.
Joel Morse
Joel Morse is the co-founder and CEO of Curavit Clinical Research, a virtual contract research organization (VCRO) that designs and runs decentralized clinical trials for digital therapeutics, devices and drugs. A mechanical engineer turned serial healthcare operator, he previously co-founded C3i Solutions in 1993 and built it into a global leader in tech-enabled clinical trial services before selling to Telerx in 2014. At Curavit he is betting that trials can be run where patients actually live, stitching together wearables, web recruitment and real-world evidence to reach people traditional sites never see.